Intas Pharmaceuticals Limited Vs C.C.E.-Ahmedabad-ii (CESTAT Ahmedabad)
Introduction: The recent order from the CESTAT Ahmedabad in the case of Intas Pharmaceuticals Limited vs. C.C.E.-Ahmedabad-II addresses the eligibility of CENVAT credit under Rule 6(3A) of the Cenvat Credit Rules, 2004. The appellant, engaged in the manufacture of medicaments, had reversed CENVAT credit on a monthly basis under Rule 6(3A) but faced issues related to the quantification of reversible amounts.
1. Background and Reversal of Credit:
- The appellant, following Rule 6(3A), reversed CENVAT credit monthly and claimed re-credit based on the final determination.
- A show cause notice was issued, alleging non-inclusion of certain credit amounts during quantification, leading to a proposed demand.
2. Show Cause Notice Allegations:
- The notice contended non-inclusion of credit amounting to Rs. 1,58,66,384/- related to services specified in Rule 6(5) availed in the year 2011-12.
- Another allegation was the wrongful availing of Rs. 3,52,69,062/- in October and December 2012, pertaining to the financial year 2011-12.
3. Adjudication and Decision:
- The Adjudicating Authority upheld the demand related to the non-inclusion of Rule 6(5) credit, rejecting the contention that services were received before the rule’s omission on 01.04.2011.
- While acknowledging the appellant’s eligibility for excluding the credit pertaining to October and December 2012, a demand was confirmed for the Rule 6(5) credit.
- Interest and a penalty under Rule 15 of the Cenvat Credit Rules, 2004, were also imposed.
4. Appellant’s Submissions and CESTAT’s Observations:
Want to Read the Complete Judgment?
You have read the free case summary. Unlock the full judgment, the detailed judicial reasoning and the downloadable PDF, along with every other premium judgment on TaxGuru.
Already subscribed? Log in
One subscription covers the entire premium judgment library, not just this case.


